BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 27, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 20, 2011
View Archived Issues
Novel pyridin-2-ylmethylamine derivatives inhibit beta-amyloid aggregation in vitro
Read More
Shionogi & Co. presents new endothelial lipase inhibitors
Read More
Scientists at Bristol-Myers Squibb synthesize new HCV NS5A inhibitors
Read More
New aminopyrimidine gamma-secretase modulators show promise as AD therapeutics in vivo
Read More
Novel inhibitors of tyrosine-protein kinase SYK patented
Read More
Activity in models of AD observed with new small-molecule beta-amyloid toxicity inhibitor
Read More
Meiji Seika discloses new triterpene derivatives for HCV infection
Read More
Phase I tolerability data presented on CHF-5074
Read More
New estrogen-related receptor-alpha inverse agonists reported
Read More
Graceway Pharmaceuticals gains FDA approval for Zyclara cream
Read More
Seek completes proof-of-efficacy phase Ib/II trial of HIV-v vaccine
Read More
Phase II study begins for CNV-1014802 in pain
Read More
Roche to acquire mtm laboratories
Read More
Pfizer withdraws application to extend Macugen indication in E.U.
Read More
Novartis launches Exelon patch in Japan
Read More
Janssen launches Tramcet combination tablet in Japan
Read More
FDA clears Luminex's xTAG RVP FAST frontline respiratory panel
Read More
BrainStorm Cell Therapeutics and U.S. medical centers prepare for ALS trial collaboration
Read More
FDA committee issues opinion on approval of dapagliflozin for type 2 diabetes
Read More
Allergan enters definitive agreement to acquire Vicept Therapeutics
Read More
Alkermes provides update on merger and product portfolio
Read More
Galapagos small-molecule SARM enters proof-of-mechanism phase I trial
Read More
Cel-Sci and Teva Pharmaceutical extend Multikine licensing agreement
Read More
Shionogi to acquire nine marketed products from Victory Pharma
Read More
